This contract involves the supply of an automated system for managing and storing medications at the Hospital Reina Sofía in Tudela, Spain. The system aims to enhance the efficiency and safety of medication storage and retrieval processes. Suppliers are invited to provide a solution that meets the h
Contract awarded. Originally published 9 months ago.
This contract opportunity involves the supply of hybrid capture massive sequencing equipment for the Health Service of Navarra (HUN). The equipment is essential for diagnostic and radiodiagnostic purposes in the health sector. Suppliers are invited to submit their proposals by the deadline of Octobe
This contract involves the supply of ultrasound machines for various Primary Care Centers under the SNS-O (Navarre Health Service). The total value of the contract is €274,680. The aim is to enhance diagnostic capabilities in primary healthcare settings. Suppliers are invited to provide high-quality
This contract, identified as APRO 235/2025, involves the supply of bone conduction and middle ear hearing implants. The total value of the contract is €543,967.42. It is part of the health sector and is managed by the Navarra Health Service (Servicio Navarro de Salud - Osasunbidea) in Spain. Supplie
This contract involves the supply of three specific pharmaceutical products: Bortezomib, Daptomycin, and Darunavir. These products are intended for use in the pharmacy services of health centers under the Navarra Health Service (SNS-O). The total value of the contract is €321,360. Suppliers interest
The KKH (Kaufmännische Krankenkasse) is seeking to establish non-exclusive discount agreements with pharmaceutical companies for specific active ingredients under the Open-House procedure. This opportunity is open to all qualified pharmaceutical companies interested in entering into discount agreeme
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a (8) of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interested pharm
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
